NVAX Annual Net Income
-$545.06 M
+$112.88 M+17.16%
31 December 2023
Summary:
As of January 21, 2025, NVAX annual net profit is -$545.06 million, with the most recent change of +$112.88 million (+17.16%) on December 31, 2023. During the last 3 years, it has fallen by -$126.80 million (-30.32%). NVAX annual net income is now -12012.49% below its all-time high of -$4.50 million, reached on December 31, 1997.NVAX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVAX Quarterly Net Income
-$121.30 M
-$283.68 M-174.70%
30 September 2024
Summary:
As of January 21, 2025, NVAX quarterly net profit is -$121.30 million, with the most recent change of -$283.68 million (-174.70%) on September 30, 2024. Over the past year, it has increased by +$9.48 million (+7.25%). NVAX quarterly net income is now -159.63% below its all-time high of $203.41 million, reached on March 31, 2022.NVAX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVAX TTM Net Income
-$284.86 M
+$9.48 M+3.22%
30 September 2024
Summary:
As of January 21, 2025, NVAX TTM net profit is -$284.86 million, with the most recent change of +$9.48 million (+3.22%) on September 30, 2024. Over the past year, it has increased by +$264.06 million (+48.11%). NVAX TTM net income is now -23638.17% below its all-time high of -$1.20 million, reached on March 31, 1996.NVAX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVAX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.2% | +7.3% | +48.1% |
| 3 y3 years | -30.3% | +85.7% | +83.7% |
| 5 y5 years | -195.0% | -369.0% | -147.0% |
NVAX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +68.7% | -159.6% | +85.7% | at high | +83.7% |
| 5 y | 5-year | -310.8% | +68.7% | -159.6% | +85.7% | -205.4% | +83.7% |
| alltime | all time | <-9999.0% | +68.7% | -159.6% | +85.7% | <-9999.0% | +83.7% |
Novavax Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$121.30 M(-174.7%) | -$284.86 M(-3.2%) |
| June 2024 | - | $162.38 M(-210.1%) | -$294.33 M(-26.2%) |
| Mar 2024 | - | -$147.55 M(-17.3%) | -$398.71 M(-26.9%) |
| Dec 2023 | -$545.06 M(-17.2%) | -$178.39 M(+36.4%) | -$545.06 M(-0.7%) |
| Sept 2023 | - | -$130.78 M(-325.4%) | -$548.92 M(-6.4%) |
| June 2023 | - | $58.01 M(-119.7%) | -$586.76 M(-49.2%) |
| Mar 2023 | - | -$293.90 M(+61.3%) | -$1.16 B(+75.6%) |
| Dec 2022 | -$657.94 M(-62.3%) | -$182.25 M(+8.1%) | -$657.94 M(-50.2%) |
| Sept 2022 | - | -$168.61 M(-67.0%) | -$1.32 B(-10.4%) |
| June 2022 | - | -$510.49 M(-351.0%) | -$1.48 B(+12.0%) |
| Mar 2022 | - | $203.41 M(-124.0%) | -$1.32 B(-24.4%) |
| Dec 2021 | -$1.74 B(+316.9%) | -$846.28 M(+162.5%) | -$1.74 B(+62.2%) |
| Sept 2021 | - | -$322.43 M(-8.5%) | -$1.08 B(+13.2%) |
| June 2021 | - | -$352.32 M(+58.2%) | -$949.91 M(+54.4%) |
| Mar 2021 | - | -$222.72 M(+25.4%) | -$615.11 M(+47.1%) |
| Dec 2020 | -$418.26 M(+215.2%) | -$177.56 M(-10.0%) | -$418.26 M(+53.5%) |
| Sept 2020 | - | -$197.31 M(+1026.1%) | -$272.52 M(+192.2%) |
| June 2020 | - | -$17.52 M(-32.3%) | -$93.26 M(-19.1%) |
| Mar 2020 | - | -$25.86 M(-18.7%) | -$115.34 M(-13.1%) |
| Dec 2019 | -$132.69 M(-28.2%) | -$31.83 M(+76.4%) | -$132.69 M(-11.7%) |
| Sept 2019 | - | -$18.04 M(-54.4%) | -$150.20 M(-15.0%) |
| June 2019 | - | -$39.60 M(-8.4%) | -$176.72 M(-2.7%) |
| Mar 2019 | - | -$43.22 M(-12.4%) | -$181.61 M(-1.7%) |
| Dec 2018 | -$184.75 M(+0.5%) | -$49.33 M(+10.7%) | -$184.75 M(-0.8%) |
| Sept 2018 | - | -$44.57 M(+0.2%) | -$186.26 M(-0.0%) |
| June 2018 | - | -$44.49 M(-4.0%) | -$186.29 M(+0.0%) |
| Mar 2018 | - | -$46.35 M(-8.8%) | -$186.27 M(+1.4%) |
| Dec 2017 | -$183.77 M(-34.4%) | -$50.84 M(+14.0%) | -$183.77 M(-3.3%) |
| Sept 2017 | - | -$44.61 M(+0.3%) | -$190.03 M(-10.2%) |
| June 2017 | - | -$44.47 M(+1.4%) | -$211.68 M(-14.1%) |
| Mar 2017 | - | -$43.85 M(-23.2%) | -$246.57 M(-11.9%) |
| Dec 2016 | -$279.97 M(+78.4%) | -$57.11 M(-13.8%) | -$279.97 M(-7.2%) |
| Sept 2016 | - | -$66.25 M(-16.5%) | -$301.66 M(+12.3%) |
| June 2016 | - | -$79.35 M(+2.7%) | -$268.53 M(+28.0%) |
| Mar 2016 | - | -$77.25 M(-2.0%) | -$209.82 M(+33.7%) |
| Dec 2015 | -$156.94 M(+89.2%) | -$78.81 M(+137.9%) | -$156.94 M(+43.1%) |
| Sept 2015 | - | -$33.12 M(+60.5%) | -$109.68 M(+13.9%) |
| June 2015 | - | -$20.64 M(-15.3%) | -$96.28 M(+3.0%) |
| Mar 2015 | - | -$24.37 M(-22.7%) | -$93.51 M(+12.7%) |
| Dec 2014 | -$82.95 M(+59.6%) | -$31.55 M(+59.9%) | -$82.95 M(+26.7%) |
| Sept 2014 | - | -$19.73 M(+10.4%) | -$65.45 M(+7.3%) |
| June 2014 | - | -$17.86 M(+29.4%) | -$61.03 M(+9.4%) |
| Mar 2014 | - | -$13.81 M(-1.7%) | -$55.80 M(+7.3%) |
| Dec 2013 | -$51.98 M(+82.4%) | -$14.05 M(-8.1%) | -$51.98 M(+13.1%) |
| Sept 2013 | - | -$15.30 M(+21.1%) | -$45.96 M(+21.3%) |
| June 2013 | - | -$12.63 M(+26.4%) | -$37.88 M(+21.5%) |
| Mar 2013 | - | -$10.00 M(+24.4%) | -$31.17 M(+9.3%) |
| Dec 2012 | -$28.51 M(+47.2%) | -$8.04 M(+11.3%) | -$28.51 M(+17.9%) |
| Sept 2012 | - | -$7.22 M(+21.9%) | -$24.18 M(+19.9%) |
| June 2012 | - | -$5.92 M(-19.3%) | -$20.17 M(+4.8%) |
| Mar 2012 | - | -$7.34 M(+98.0%) | -$19.25 M(-0.6%) |
| Dec 2011 | -$19.36 M(-45.8%) | -$3.71 M(+15.3%) | -$19.36 M(-11.8%) |
| Sept 2011 | - | -$3.21 M(-35.7%) | -$21.94 M(-24.2%) |
| June 2011 | - | -$4.99 M(-33.0%) | -$28.95 M(-11.8%) |
| Mar 2011 | - | -$7.45 M(+18.6%) | -$32.82 M(-8.1%) |
| Dec 2010 | -$35.71 M | -$6.29 M(-38.5%) | -$35.71 M(-21.3%) |
| Sept 2010 | - | -$10.22 M(+15.4%) | -$45.35 M(+6.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2010 | - | -$8.86 M(-14.4%) | -$42.66 M(+0.7%) |
| Mar 2010 | - | -$10.34 M(-35.1%) | -$42.34 M(+4.9%) |
| Dec 2009 | -$40.35 M(+11.9%) | -$15.93 M(+111.5%) | -$40.35 M(+13.7%) |
| Sept 2009 | - | -$7.53 M(-11.8%) | -$35.50 M(-0.9%) |
| June 2009 | - | -$8.54 M(+2.3%) | -$35.81 M(-2.3%) |
| Mar 2009 | - | -$8.35 M(-24.6%) | -$36.64 M(+1.6%) |
| Dec 2008 | -$36.05 M(+3.7%) | -$11.08 M(+41.3%) | -$36.05 M(+5.4%) |
| Sept 2008 | - | -$7.84 M(-16.3%) | -$34.19 M(-3.2%) |
| June 2008 | - | -$9.37 M(+20.9%) | -$35.31 M(+3.5%) |
| Mar 2008 | - | -$7.75 M(-15.9%) | -$34.13 M(-1.8%) |
| Dec 2007 | -$34.77 M(+50.7%) | -$9.22 M(+2.8%) | -$34.77 M(+9.7%) |
| Sept 2007 | - | -$8.97 M(+9.4%) | -$31.70 M(+14.2%) |
| June 2007 | - | -$8.19 M(-2.3%) | -$27.74 M(+6.9%) |
| Mar 2007 | - | -$8.39 M(+36.4%) | -$25.96 M(+12.5%) |
| Dec 2006 | -$23.07 M(+106.4%) | -$6.15 M(+22.6%) | -$23.07 M(+114.3%) |
| Sept 2006 | - | -$5.01 M(-21.8%) | -$10.77 M(+27.0%) |
| June 2006 | - | -$6.41 M(+16.7%) | -$8.48 M(+8.9%) |
| Mar 2006 | - | -$5.50 M(-189.3%) | -$7.78 M(-30.3%) |
| Dec 2005 | -$11.17 M(-56.9%) | $6.16 M(-325.7%) | -$11.17 M(-59.5%) |
| Sept 2005 | - | -$2.73 M(-52.3%) | -$27.62 M(+0.3%) |
| June 2005 | - | -$5.72 M(-35.7%) | -$27.55 M(-6.8%) |
| Mar 2005 | - | -$8.89 M(-13.6%) | -$29.55 M(+14.0%) |
| Dec 2004 | -$25.92 M(+50.1%) | -$10.29 M(+287.2%) | -$25.92 M(+38.5%) |
| Sept 2004 | - | -$2.66 M(-65.6%) | -$18.71 M(-3.6%) |
| June 2004 | - | -$7.72 M(+46.8%) | -$19.42 M(+16.1%) |
| Mar 2004 | - | -$5.26 M(+70.5%) | -$16.73 M(-3.1%) |
| Dec 2003 | -$17.27 M(-23.9%) | -$3.08 M(-8.3%) | -$17.27 M(-6.8%) |
| Sept 2003 | - | -$3.36 M(-33.2%) | -$18.54 M(-15.9%) |
| June 2003 | - | -$5.03 M(-13.3%) | -$22.03 M(-3.3%) |
| Mar 2003 | - | -$5.80 M(+33.5%) | -$22.78 M(+0.4%) |
| Dec 2002 | -$22.70 M(+132.9%) | -$4.34 M(-36.6%) | -$22.70 M(+5.4%) |
| Sept 2002 | - | -$6.85 M(+18.6%) | -$21.55 M(+25.2%) |
| June 2002 | - | -$5.78 M(+1.0%) | -$17.20 M(+30.0%) |
| Mar 2002 | - | -$5.72 M(+79.3%) | -$13.23 M(+35.8%) |
| Dec 2001 | -$9.74 M(-20.1%) | -$3.19 M(+27.0%) | -$9.74 M(-15.6%) |
| Sept 2001 | - | -$2.51 M(+39.0%) | -$11.54 M(-5.7%) |
| June 2001 | - | -$1.81 M(-19.0%) | -$12.24 M(-6.4%) |
| Mar 2001 | - | -$2.23 M(-55.2%) | -$13.07 M(+7.2%) |
| Dec 2000 | -$12.19 M(+170.9%) | -$4.99 M(+55.2%) | -$12.19 M(+48.6%) |
| Sept 2000 | - | -$3.21 M(+21.7%) | -$8.20 M(+20.8%) |
| June 2000 | - | -$2.64 M(+95.6%) | -$6.79 M(+34.5%) |
| Mar 2000 | - | -$1.35 M(+35.0%) | -$5.05 M(+9.8%) |
| Dec 1999 | -$4.50 M(-6.3%) | -$1.00 M(-44.4%) | -$4.60 M(-13.2%) |
| Sept 1999 | - | -$1.80 M(+100.0%) | -$5.30 M(+12.8%) |
| June 1999 | - | -$900.00 K(0.0%) | -$4.70 M(-4.1%) |
| Mar 1999 | - | -$900.00 K(-47.1%) | -$4.90 M(+2.1%) |
| Dec 1998 | -$4.80 M(+6.7%) | -$1.70 M(+41.7%) | -$4.80 M(+17.1%) |
| Sept 1998 | - | -$1.20 M(+9.1%) | -$4.10 M(+2.5%) |
| June 1998 | - | -$1.10 M(+37.5%) | -$4.00 M(0.0%) |
| Mar 1998 | - | -$800.00 K(-20.0%) | -$4.00 M(-9.1%) |
| Dec 1997 | -$4.50 M(-18.2%) | -$1.00 M(-9.1%) | -$4.40 M(-17.0%) |
| Sept 1997 | - | -$1.10 M(0.0%) | -$5.30 M(+1.9%) |
| June 1997 | - | -$1.10 M(-8.3%) | -$5.20 M(-5.5%) |
| Mar 1997 | - | -$1.20 M(-36.8%) | -$5.50 M(0.0%) |
| Dec 1996 | -$5.50 M | -$1.90 M(+90.0%) | -$5.50 M(+52.8%) |
| Sept 1996 | - | -$1.00 M(-28.6%) | -$3.60 M(+38.5%) |
| June 1996 | - | -$1.40 M(+16.7%) | -$2.60 M(+116.7%) |
| Mar 1996 | - | -$1.20 M | -$1.20 M |
FAQ
- What is Novavax annual net profit?
- What is the all time high annual net income for Novavax?
- What is Novavax annual net income year-on-year change?
- What is Novavax quarterly net profit?
- What is the all time high quarterly net income for Novavax?
- What is Novavax quarterly net income year-on-year change?
- What is Novavax TTM net profit?
- What is the all time high TTM net income for Novavax?
- What is Novavax TTM net income year-on-year change?
What is Novavax annual net profit?
The current annual net income of NVAX is -$545.06 M
What is the all time high annual net income for Novavax?
Novavax all-time high annual net profit is -$4.50 M
What is Novavax annual net income year-on-year change?
Over the past year, NVAX annual net profit has changed by +$112.88 M (+17.16%)
What is Novavax quarterly net profit?
The current quarterly net income of NVAX is -$121.30 M
What is the all time high quarterly net income for Novavax?
Novavax all-time high quarterly net profit is $203.41 M
What is Novavax quarterly net income year-on-year change?
Over the past year, NVAX quarterly net profit has changed by +$9.48 M (+7.25%)
What is Novavax TTM net profit?
The current TTM net income of NVAX is -$284.86 M
What is the all time high TTM net income for Novavax?
Novavax all-time high TTM net profit is -$1.20 M
What is Novavax TTM net income year-on-year change?
Over the past year, NVAX TTM net profit has changed by +$264.06 M (+48.11%)